Get started
First Trust NYSE Arca Biotechnology Index FundFirst Trust NYSE Arca Biotechnology Index FundFirst Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund

No trades
See on Supercharts
Overview
Chart Analysis Holdings News Ideas Discussions Seasonals

FBT chart



Key stats


Assets under management (AUM)
‪1.06 B‬ USD
Fund flows (1Y)
—
Dividend yield (indicated)
0.67%
Discount/Premium to NAV
—
Shares outstanding
‪6.10 M‬
Expense ratio
0.54%

About First Trust NYSE Arca Biotechnology Index Fund


Issuer
AJM Ventures LLC
Brand
First Trust
Home page
ftportfolios.com
Inception date
Jun 19, 2006
Structure
Open-Ended Fund
Index tracked
NYSE Arca Biotechnology Index
Replication method
Physical
Management style
Passive
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
First Trust Advisors LP
Distributor
First Trust Portfolios LP
ISIN
US33733E2037
FBT provides exposure to biotech companies involved in the use of biological processes to develop products or provide services. The underlying index contains 30 names, an increase from 20 in October 2014. Without a specific sector classification scheme, the funds broad exposure could include access to pharmaceuticals and medical technology in addition to traditional biotech. Still, FBTs equal weighting of about 30 stocks produces a relatively concentrated basket. The index is reconstituted and rebalanced quarterly.

Broaden your horizons with more funds linked to FBT via country, focus, and more.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Equal
Geography
U.S.
Weighting scheme
Equal
Selection criteria
Market cap

FBT analysis


What's in the fund
Exposure type
StocksBonds, Cash & Other
Health Technology
Stock breakdown by region
81%18%
Top 10 holdings

FBT news



Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
FBT assets under management is ‪1.06 B‬ USD. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
FBT invests in stocks. See more details in our Analysis section.
FBT expense ratio is 0.54%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, FBT isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
Yes, FBT pays dividends to its holders with the dividend yield of 0.67%.
FBT shares are issued by AJM Ventures LLC
FBT follows the NYSE Arca Biotechnology Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Jun 19, 2006.
The fund's management style is passive, meaning it's aiming to replicate the performance of the underlying index by holding assets in the same proportions as the index. The goal is to match the index's returns.